Clinical Research Division

Lymphoma Program

The Lymphoma Program brings together physicians from the University of Washington and Fred Hutchinson Cancer Research Center to treat patients with advanced lymphoma.

While standard therapies are offered, the focus of the Lymphoma Program is on clinical trials. To learn more about clinical trials for lymphoma, review the clinical trials search results.

Outpatients are seen at the Seattle Cancer Care Alliance and inpatients at the UW Medical Center.

Researchers

Associate Professor, Medical Oncology Division, University of Washington School of Medicine
Director of Clinical Research, Hematology Malignancies/Hematology, Seattle Cancer Care Alliance
Developing novel targeted therapies for lymphomas with particular emphasis on radioimmunotherapy-based transplant conditioning regimens, low toxicity proapoptotic agents for indolent lymphomas, and safe curative regimens for older adults with lymphoma.
Phone: (206) 667-6533
Fax: (206) 667-6358
Associate Professor, Department of Medicine and Oncology, University of Washington
Research is focused on trying to augment the immune system after an autologous transplant. A number of clinical trials using different approaches have been developed.
Phone: (206) 667-6447
Fax: (206) 667-4937
Professor of Medicine, University of Washington
Attending Physician, Seattle Cancer Care Alliance
Improving treatments for patients with CLL, lymphoma and myeloma by increasing activity and decreasing toxicity
Phone: (206) 667-5616
Fax: (206) 667-6124
Member and Interim Director, Clinical Research Division
Professor of Medicine, University of Washington
Adjunct Professor of Bioengineering, University of Washington
Co-Director, Center for Intracellular Delivery of Biologics and Nanotechnology Training Program, University of Washington
Recipient, Dr. Penny E. Peterson Memorial Chair for Lymphoma Research, Clinical Research Division
Phone: (206) 667-1864
Email: press@uw.edu
Fax: (206) 667-1874